These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2415240)

  • 41. DHFR and MSH3 co-amplification in childhood acute lymphoblastic leukaemia, in vitro and in vivo.
    Matheson EC; Hogarth LA; Case MC; Irving JA; Hall AG
    Carcinogenesis; 2007 Jun; 28(6):1341-6. PubMed ID: 17148505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase.
    Volpato JP; Fossati E; Pelletier JN
    J Mol Biol; 2007 Oct; 373(3):599-611. PubMed ID: 17868689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.
    Jolivet J; Chabner BA
    J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of novel antifolates against human squamous carcinoma cell lines of the head and neck with inherent resistance to methotrexate.
    van der Laan BF; Jansen G; Kathmann GA; Westerhof GR; Schornagel JH; Hordijk GJ
    Int J Cancer; 1992 Jul; 51(6):909-14. PubMed ID: 1639538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of sensitivity and natural resistance to antifolates in a methylcholanthrene-induced rat sarcoma.
    Li WW; Lin JT; Schweitzer BI; Bertino JR
    Mol Pharmacol; 1991 Nov; 40(5):854-8. PubMed ID: 1719370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Membrane transport of methotrexate in a squamous carcinoma cell line adapted to low folate concentrations.
    van der Laan BF; Jansen G; van Gestel JA; Schornagel JH; Hordijk GJ
    Anticancer Res; 1991; 11(3):1265-8. PubMed ID: 1888158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selectively weakened binding of methotrexate by human dihydrofolate reductase allows rapid ex vivo selection of mammalian cells.
    Volpato JP; Mayotte N; Fossati E; Guerrero V; Sauvageau G; Pelletier JN
    J Mol Recognit; 2011; 24(2):188-98. PubMed ID: 21360609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms of acquired resistance to methotrexate in a human squamous carcinoma cell line of the head and neck, exposed to different treatment schedules.
    van der Laan BF; Jansen G; Kathmann I; Schornagel JH; Hordijk GJ
    Eur J Cancer; 1991; 27(10):1274-8. PubMed ID: 1835598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Murine erythroleukemia cell variants: isolation of cells that have amplified the dihydrofolate reductase gene and retained the ability to be induced to differentiate.
    Corin RE; Turner T; Szabo P
    Biochemistry; 1986 Jul; 25(13):3768-73. PubMed ID: 3461851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dihydrofolate reductase gene expression characterized by the PCR assay in human leukemia cells.
    Miyachi H; Han H; Scanlon KJ
    In Vivo; 1991; 5(1):7-12. PubMed ID: 1932630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Mechanisms of resistance to methotrexate].
    Fanin R; Aschele C; Volkendandt M; Trippett TM; Lin JT; Bertino JR
    Haematologica; 1991 Jun; 76 Suppl 3():184-7. PubMed ID: 1721601
    [No Abstract]   [Full Text] [Related]  

  • 52. Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with decreased binding to methotrexate in a human colon carcinoma cell line, HCT-8R4, resistant to this drug.
    Srimatkandada S; Schweitzer BI; Moroson BA; Dube S; Bertino JR
    J Biol Chem; 1989 Feb; 264(6):3524-8. PubMed ID: 2914962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A single point mutation in Drosophila dihydrofolate reductase confers methotrexate resistance to a transgenic CHO cell line.
    Neumann K; Al-Batayneh KM; Kuiper MJ; Parsons-Sheldrake J; Tyshenko MG; Flintoff WF; Cole SP; Walker VK
    Genome; 2003 Aug; 46(4):707-15. PubMed ID: 12897877
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impaired drug uptake in methotrexate resistant Crithidia fasciculata without changes in dihydrofolate reductase activity or gene amplification.
    Dewes H; Ostergaard HL; Simpson L
    Mol Biochem Parasitol; 1986 May; 19(2):149-61. PubMed ID: 3724795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms of natural resistance to antifolates in human soft tissue sarcomas.
    Li WW; Lin JT; Tong WP; Trippett TM; Brennan MF; Bertino JR
    Cancer Res; 1992 Mar; 52(6):1434-8. PubMed ID: 1371715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of the propensity for gene amplification between near-tetraploid and near-diploid V79 clones resistant to 150 nM methotrexate.
    Hashimoto MW; Nikaido O; Kobayashi N; Chang CC; Trosko JE; Mori T
    Carcinogenesis; 1996 Mar; 17(3):389-94. PubMed ID: 8631121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enzyme studies of methotrexate-resistant human leukemic cell (K562) subclones.
    Koizumi S; Allegra CJ
    Leuk Res; 1992; 16(6-7):565-9. PubMed ID: 1378915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 2-tier bacterial and in vitro selection of active and methotrexate-resistant variants of human dihydrofolate reductase.
    Fossati E; Volpato JP; Poulin L; Guerrero V; Dugas DA; Pelletier JN
    J Biomol Screen; 2008 Jul; 13(6):504-14. PubMed ID: 18566481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of variant dihydrofolate reductase with decreased binding affinity to antifolates in MOLT-3 human leukemia cell lines resistant to trimetrexate.
    Miyachi H; Takemura Y; Kobayashi H; Ando Y
    Cancer Lett; 1995 Jan; 88(1):93-9. PubMed ID: 7850779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotides.
    Morganti M; Coronnello M; Caciagli B; Biondi C; Quattrone A; Capaccioli S; Mazzei T; Mini E
    Anticancer Drugs; 2000 Apr; 11(4):285-94. PubMed ID: 10898545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.